Next Generation Sequencing (NGS) Industry Insights | Companies like Illumina are increasing their installation base by providing sequencing services in different emerging countries

The global Next Generation Sequencing market size was valued at USD 8.49 billion in 2018 and is expected to register a CAGR of 12.78% over the forecast period. Introduction of advanced and rapid sequencing technologies for clinical processes is expected to drive the market.

(firmenpresse) - The global next generation sequencing market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc. Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market. These novel strategies mark the presence of intense competition between the key firms. Companies are further increasing their installation base by providing sequencing services in different emerging countries. For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology

Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine. NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing. Wide application of this technique in oncology, reproductive screening, infectious disease, noninvasive prenatal testing and pharmacogenomics is also expected to positively impact the market growth. Reduced costs of genetic sequencing has also significantly enhanced the adoption of these technologies.
Reduced installation costs of NGS platforms and easy availability of proteomic and genomic data has also resulted in an increased demand, thereby propelling the market development.

Further key findings from the study suggest:
& related products account for the dominant market share due to the presence of sequencing platforms and instruments required for clinical applications

















&A are some of the key strategies adopted by these companies, for instance, Illumina acquired Edico Genome to improve the overall efficiency of NGS solutions provided by Illumina

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Leseranfragen:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: HexaResearch
Datum: 12.09.2019 - 02:45 Uhr
Sprache: Deutsch
News-ID 1552124
Anzahl Zeichen: 3661

contact information:
Contact person:
Town:

San Francisco

Phone: 1-888- 202-9519

Kategorie:

Pharmaceuticals & Biotech

Typ of Press Release: Financial
type of sending: send
Date of sending: 12.09.2019
Anmerkungen:


Diese Pressemitteilung wurde bisher 972 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Next Generation Sequencing (NGS) Industry Insights | Companies like Illumina are increasing their installation base by providing sequencing services in different emerging countries
"
steht unter der journalistisch-redaktionellen Verantwortung von

Grand View Research, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Alle Meldungen von Grand View Research, Inc.